Package 10122-502-01

Brand: revcovi

Generic: elapegademase-lvlr
NDC Package

Package Facts

Identity

Package NDC 10122-502-01
Digits Only 1012250201
Product NDC 10122-502
Description

1 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2018-10-05
Brand revcovi
Generic elapegademase-lvlr
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "964401e1-52e5-4c34-b5b5-d028ce092dd9", "openfda": {"unii": ["9R3D3Y0UHS"], "rxcui": ["2059223", "2059228"], "spl_set_id": ["8c073f84-cdd0-40e4-b3a9-172687267f28"], "manufacturer_name": ["Chiesi USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (10122-502-01)  / 1.5 mL in 1 VIAL", "package_ndc": "10122-502-01", "marketing_start_date": "20181005"}], "brand_name": "Revcovi", "product_id": "10122-502_964401e1-52e5-4c34-b5b5-d028ce092dd9", "dosage_form": "INJECTION", "product_ndc": "10122-502", "generic_name": "elapegademase-lvlr", "labeler_name": "Chiesi USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Revcovi", "active_ingredients": [{"name": "ELAPEGADEMASE", "strength": "1.6 mg/mL"}], "application_number": "BLA761092", "marketing_category": "BLA", "marketing_start_date": "20181005", "listing_expiration_date": "20261231"}